Tenecteplase in acute ischemic stroke: a new era in thrombolysis
Tenecteplase (TNK) is a genetically engineered variant of alteplase, showing promise for acute ischemic stroke treatment. With a longer half-life and higher fibrin specificity, TNK enables more targeted and efficient clot dissolution. Clinical trials demonstrate potential advantages, including impro...
Saved in:
| Main Authors: | Gisele Sampaio Silva, Eva Rocha, Octávio Marques Pontes-Neto, Sheila Ouriques Martins |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
2025-05-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0045-1808088 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alteplase vs. Tenecteplase: An In-depth Analysis of Their Relative Effectiveness in Treating Acute Ischemic Stroke
by: Muhammad Junaid Azhar, et al.
Published: (2024-10-01) -
Tenecteplase versus alteplase in patients with acute ischemic stroke: an updated systematic review and meta-analysis
by: Abdelmonam M. Hagag, et al.
Published: (2025-08-01) -
Tenecteplase compared to alteplase in real-world outcome: A Swedish Stroke Register study
by: Mikael Skärlund, et al.
Published: (2024-10-01) -
Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center
by: Alexander Sekita, et al.
Published: (2025-05-01) -
Successful use of intra venous tenecteplase for acute ischemic stroke in pregnancy
by: Balamurugan Namasivayam, et al.
Published: (2024-09-01)